Search Results
Search for other papers by Santiago Tofé in
Google Scholar
PubMed
Search for other papers by Iñaki Argüelles in
Google Scholar
PubMed
Search for other papers by Ana Forteza in
Google Scholar
PubMed
Search for other papers by Cristina Álvarez in
Google Scholar
PubMed
Search for other papers by Alessandra Repetto in
Google Scholar
PubMed
Search for other papers by Luis Masmiquel in
Google Scholar
PubMed
Search for other papers by Irene Rodríguez in
Google Scholar
PubMed
Search for other papers by Eladio Losada in
Google Scholar
PubMed
Search for other papers by Nuria Sukunza in
Google Scholar
PubMed
Search for other papers by María Cabrer in
Google Scholar
PubMed
Search for other papers by Mildred Sifontes in
Google Scholar
PubMed
Search for other papers by María del Mar del Barrio in
Google Scholar
PubMed
Search for other papers by Antonia Barceló in
Google Scholar
PubMed
Search for other papers by Álvaro Tofé in
Google Scholar
PubMed
Search for other papers by Vicente Pereg in
Google Scholar
PubMed
Introduction Thyroid cancer (TC) represents 3% of the global incidence of all cancers, with 586,000 new patients estimated in 2020 worldwide ( https://gco.iarc.fr/today/home ). It is the most frequent endocrine cancer and its global incidence
Search for other papers by Diana Borges Duarte in
Google Scholar
PubMed
Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed
Search for other papers by Guilherme Assunção in
Google Scholar
PubMed
Search for other papers by André Couto Carvalho in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
Introduction Differentiated thyroid carcinoma (DTC) is the most common endocrine gland malignancy, most frequently diagnosed among women between the ages of 45 and 54 years ( 1 , 2 ). Despite the increasing incidence worldwide over the last
Search for other papers by Inês Cosme in
Google Scholar
PubMed
Search for other papers by Ana Figueiredo in
Google Scholar
PubMed
Search for other papers by Sara Pinheiro in
Google Scholar
PubMed
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Introduction The incidence of thyroid carcinoma (TC) increased over the past 50 years ( 1 , 2 ) mainly due to a disproportionate increase in small papillary TC ( 3 ). In 2020, the GLOBOCAN database reported worldwide 586,000 cases of TC
Search for other papers by Lan Wu in
Google Scholar
PubMed
Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Search for other papers by Chen-Yang Feng in
Google Scholar
PubMed
Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Search for other papers by Yu Chen in
Google Scholar
PubMed
Search for other papers by Wei-Wei Liu in
Google Scholar
PubMed
Search for other papers by Miao-Bian Liang in
Google Scholar
PubMed
Search for other papers by Zike Zhang in
Google Scholar
PubMed
Search for other papers by Jun Yang in
Google Scholar
PubMed
Search for other papers by Su-Mei Cao in
Google Scholar
PubMed
Search for other papers by Mengmeng Li in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common cancer in the endocrine system, and its incidence rates have increased rapidly worldwide over the past decades, with relatively stable or declining mortality rates ( 1 , 2 ). The diverging gap
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Search for other papers by Daniele Ceruti in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Grzegorz Bilo in
Google Scholar
PubMed
Search for other papers by Matteo Trevisan in
Google Scholar
PubMed
Search for other papers by Noemi Giancola in
Google Scholar
PubMed
Search for other papers by Claudia Moneta in
Google Scholar
PubMed
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Search for other papers by Gianfranco Parati in
Google Scholar
PubMed
Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
most frequent toxicities recorded during both clinical trials and real-life (RL) studies and has a high incidence during LEN treatment (reviewed in Table 1 ). Indeed, in the LEN registration trial SELECT, it was recorded in 67.8% of cases, and 41.8% of
Department of Otorhinolaryngology-Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed
Search for other papers by Min Gyu Kim in
Google Scholar
PubMed
Search for other papers by Min Soo Kim in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Jae Won Chang in
Google Scholar
PubMed
Department of Otolaryngology-Head and Neck Surgery, Chungnam National University Hospital, Daejeon, Republic of Korea
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
Introduction Thyroid cancer is the most common cancer among tumors of endocrine origin. According to the Global Cancer Statistics in 2020, approximately 586,202 people are diagnosed with thyroid cancer each year, and it ranks 11th in incidence
Search for other papers by Xian Qiu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
Introduction Thyroid cancer is responsible for 586,000 cases worldwide, ranking the ninth place for incidence in 2020, with differentiated thyroid cancer (DTC) accounting for over 90% ( 1 ). For DTC at an early stage, the optimal prognosis is
Search for other papers by Luigino Dal Maso in
Google Scholar
PubMed
Search for other papers by Daniela Pierannunzio in
Google Scholar
PubMed
Search for other papers by Silvia Francisci in
Google Scholar
PubMed
Search for other papers by Angela De Paoli in
Google Scholar
PubMed
Search for other papers by Federica Toffolutti in
Google Scholar
PubMed
Search for other papers by Salvatore Vaccarella in
Google Scholar
PubMed
Search for other papers by Silvia Franceschi in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Ugo Fedeli in
Google Scholar
PubMed
Search for other papers by of the DEPTH Working Group in
Google Scholar
PubMed
in absolute numbers, from 5220 RAI treatments in 2016 to 4219 in 2018 (Supplementary Table 1). Supplementary Table 2 and Supplementary Fig. 1 show incidence rates of RAI after TT per 100,000 women and men in Italy, overall and by age, all descreasing
Search for other papers by Sang-Hyeon Ju in
Google Scholar
PubMed
Search for other papers by Yong Bae Ji in
Google Scholar
PubMed
Search for other papers by Minchul Song in
Google Scholar
PubMed
Search for other papers by Joung Youl Lim in
Google Scholar
PubMed
Search for other papers by Da Beom Heo in
Google Scholar
PubMed
Search for other papers by Min-Gyu Kim in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Search for other papers by Jae Won Chang in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed
Search for other papers by Yea Eun Kang in
Google Scholar
PubMed
Search for other papers by Eu Jeong Ku in
Google Scholar
PubMed
Search for other papers by Mijin Kim in
Google Scholar
PubMed
Search for other papers by Eun Kyung Lee in
Google Scholar
PubMed
Search for other papers by June Young Choi in
Google Scholar
PubMed
Search for other papers by Hyeong Won Yu in
Google Scholar
PubMed
Search for other papers by Young Joo Park in
Google Scholar
PubMed
Search for other papers by Jun-Ho Choe in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
Search for other papers by the MASTER study group † in
Google Scholar
PubMed
Introduction Thyroid cancer, which is the most common endocrine malignancy, has been increasing globally ( 1 , 2 ). From 1990 to 2017, the annual age-standardized incidence rate (ASIR) of thyroid cancer worldwide increased from 2.11 to 3
Search for other papers by Daniela Cavaco in
Google Scholar
PubMed
Search for other papers by Ana Filipa Martins in
Google Scholar
PubMed
Search for other papers by Rafael Cabrera in
Google Scholar
PubMed
Search for other papers by Helena Vilar in
Google Scholar
PubMed
Nova Medical School, Lisbon, Portugal
Search for other papers by Valeriano Leite in
Google Scholar
PubMed
. Hypoparathyroidism after total thyroidectomy: incidence and resolution . Journal of Surgical Research 2015 197 348 – 353 . ( https://doi.org/10.1016/j.jss.2015.04.059 ) 23 Kazaure HS Roman SA Sosa JA . Aggressive variants of papillary thyroid cancer